We are live on ! Find out more
VYGR icon

Voyager Therapeutics
VYGR

98 hedge funds and large institutions have $418M invested in Voyager Therapeutics in 2017 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 37 increasing their positions, 16 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

135% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 17

131% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 16

80% more capital invested

Capital invested by funds: $233M → $418M (+$185M)

46% more call options, than puts

Call options by funds: $1.84M | Put options by funds: $1.26M

38.03% more ownership

Funds ownership: 42.06% → 80.08% (+38%)

31% more funds holding

Funds holding: 75 → 98 (+23)

Holders
98
Holders Change
+23
Holders Change %
+30.67%
% of All Funds
2.22%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
40
Increased
37
Reduced
16
Closed
17
Calls
$1.84M
Puts
$1.26M
Net Calls
+$580K
Net Calls Change
-$3M

Top Buyers

Rank Fund Capital Flow
1
BB
BB Biotech
Switzerland
+$26.4M
2
BlackRock
BlackRock
New York
+$8.82M
3
FCM
Farallon Capital Management
California
+$8.35M
4
LCM
Laurion Capital Management
New York
+$7.94M
5
Axa
Axa
France
+$5.77M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$8.19M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$7.05M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$5.49M
4
BBA
Baker Bros. Advisors
New York
-$4.88M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$2.69M
Name Holding Trade Value Shares
Change 		Change in
Stake
Point72 Asset Management
101
Point72 Asset Management
Connecticut
– -$2.69M -130,900 Closed
MCM
102
McKinley Capital Management
Alaska
– -$1.41M -68,605 Closed
RJFSA
103
Raymond James Financial Services Advisors
Florida
– -$1.12M -54,488 Closed
PA
104
Perceptive Advisors
New York
– -$712K -34,604 Closed
Renaissance Technologies
105
Renaissance Technologies
New York
– -$686K -33,300 Closed
VF
106
Virtu Financial
New York
– -$477K -23,171 Closed
NFA
107
Nationwide Fund Advisors
Ohio
– -$407K -19,779 Closed
DCM
108
Driehaus Capital Management
Illinois
– -$407K -19,752 Closed
DS
109
DRW Securities
Illinois
– -$247K -12,000 Closed
CS
110
Credit Suisse
Switzerland
– -$226K -10,969 Closed
D.E. Shaw & Co
111
D.E. Shaw & Co
New York
– -$219K -10,621 Closed
Group One Trading
112
Group One Trading
Illinois
– -$165K -9,647 Closed
PIM
113
Partner Investment Management
California
– -$100K -4,844 Closed
Royal Bank of Canada
114
Royal Bank of Canada
Ontario, Canada
– -$49K -2,368 Closed
UBS Group
115
UBS Group
Switzerland
– -$16K -771 Closed
1 2 3 4
5

VYGR Hedge Fund Activity: Q4 2017 in Review

98 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q4 2017, worth a combined $418M — up 80% from $233M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new VYGR positions and 17 closed out — a net gain of 23 holders — while 37 added to existing stakes and 16 trimmed.

The largest buyer was BB Biotech, opening a new position worth an estimated $26.4M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $8.19M sold.

  • 98 institutional investors held Voyager Therapeutics (VYGR) as of Q4 2017, up from 75 in Q3 2017.
  • Funds reported $418M of Voyager Therapeutics stock for Q4 2017, up 80% quarter-over-quarter.
  • 40 funds opened new Voyager Therapeutics positions in Q4 2017 and 17 closed out, a net change of +23 holders.
  • The largest Voyager Therapeutics buyer in Q4 2017 was BB Biotech, an estimated $26.4M added.
  • The largest Voyager Therapeutics seller in Q4 2017 was PFM Health Sciences, an estimated $8.19M sold.

Based on aggregated 13F filings for Q4 2017.